First-in-class DLL3-targeting BiTE could be the next big player in SCLC treatment: GlobalData
The drug is forecast to achieve peak sales of $788 million by 2029
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.